Professor Patrick Gunning discusses his work developing small molecule inhibitors for STAT proteins, with the aim of developing new cancer treatments. STAT-3 is found to be hyperactive in over 70% of human cancer, leading to uncontrolled cell growth, whilst STAT-5 has recently been identified as a target in haematological oncology.

This video won the Drug Discovery & Development Video Interview of the Year in the 2018 Scientists' Choice Awards. Find out more about the awards here